share_log

Assessing RxSight: Insights From 8 Financial Analysts

Benzinga ·  Apr 11 08:00

RxSight (NASDAQ:RXST) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings44000
Last 30D10000
1M Ago00000
2M Ago32000
3M Ago02000

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $59.12, a high estimate of $64.00, and a low estimate of $50.00. This upward trend is evident, with the current average reflecting a 21.0% increase from the previous average price target of $48.86.

price target chart

Understanding Analyst Ratings: A Comprehensive Breakdown

In examining recent analyst actions, we gain insights...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment